Pennant Group [PNTG] vs Select Medical [SEM] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pennant Group wins in 7 metrics, Select Medical wins in 12 metrics, with 0 ties. Select Medical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricPennant GroupSelect MedicalBetter
P/E Ratio (TTM)29.6623.21Select Medical
Price-to-Book Ratio2.561.07Select Medical
Debt-to-Equity Ratio105.10136.22Pennant Group
PEG Ratio20.876.37Select Medical
EV/EBITDA22.8112.71Select Medical
Profit Margin (TTM)3.40%3.33%Pennant Group
Operating Margin (TTM)6.03%8.33%Select Medical
EBITDA Margin (TTM)6.03%8.33%Select Medical
Return on Equity11.41%7.72%Pennant Group
Return on Assets (TTM)4.00%2.42%Pennant Group
Free Cash Flow (TTM)$30.31M$295.69MSelect Medical
Dividend YieldN/A65.77%N/A
1-Year Return-26.51%-32.42%Pennant Group
Price-to-Sales Ratio (TTM)1.040.35Select Medical
Enterprise Value$1.12B$4.91BSelect Medical
EV/Revenue Ratio1.490.94Select Medical
Gross Profit Margin (TTM)14.00%13.34%Pennant Group
Revenue per Share (TTM)$23$42Select Medical
Earnings per Share (Diluted)$0.76$0.62Pennant Group
Beta (Stock Volatility)1.481.20Select Medical
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends

Pennant Group vs Select Medical Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pennant Group7.75%8.80%-6.69%-13.11%-9.29%-8.84%
Select Medical1.34%-19.54%-19.70%-20.77%-36.80%-36.67%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pennant Group-26.51%27.42%-37.73%39.13%39.13%39.13%
Select Medical-32.42%-20.40%11.84%61.25%215.65%118.75%

Performance & Financial Health Analysis: Pennant Group vs Select Medical

MetricPNTGSEM
Market Information
Market Cap i$776.93M$1.85B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i247,9391,083,480
90 Day Avg. Volume i306,8861,361,833
Last Close$25.99$12.06
52 Week Range$21.18 - $37.13$11.65 - $22.08
% from 52W High-30.00%-45.38%
All-Time High$69.56 (Jan 04, 2021)$23.49 (Jun 21, 2021)
% from All-Time High-62.64%-48.66%
Growth Metrics
Quarterly Revenue Growth0.34%0.02%
Quarterly Earnings Growth0.59%-0.42%
Financial Health
Profit Margin (TTM) i0.03%0.03%
Operating Margin (TTM) i0.06%0.08%
Return on Equity (TTM) i0.11%0.08%
Debt to Equity (MRQ) i105.10136.22
Cash & Liquidity
Book Value per Share (MRQ)$8.81$13.40
Cash per Share (MRQ)$0.15$0.41
Operating Cash Flow (TTM) i$17.52M$581.10M
Levered Free Cash Flow (TTM) i$4.89M$218.65M
Dividends
Last 12-Month Dividend Yield iN/A65.77%
Last 12-Month Dividend iN/A$9.82

Valuation & Enterprise Metrics Analysis: Pennant Group vs Select Medical

MetricPNTGSEM
Price Ratios
P/E Ratio (TTM) i29.6623.21
Forward P/E i20.876.37
PEG Ratio i20.876.37
Price to Sales (TTM) i1.040.35
Price to Book (MRQ) i2.561.07
Market Capitalization
Market Capitalization i$776.93M$1.85B
Enterprise Value i$1.12B$4.91B
Enterprise Value Metrics
Enterprise to Revenue i1.490.94
Enterprise to EBITDA i22.8112.71
Risk & Other Metrics
Beta i1.481.20
Book Value per Share (MRQ) i$8.81$13.40

Financial Statements Comparison: Pennant Group vs Select Medical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PNTGSEM
Revenue/Sales i$209.84M$1.35B
Cost of Goods Sold i$180.46M$1.17B
Gross Profit i$29.38M$180.56M
Research & Development iN/AN/A
Operating Income (EBIT) i$12.65M$112.75M
EBITDA i$14.47M$160.07M
Pre-Tax Income i$11.38M$96.19M
Income Tax i$2.85M$21.45M
Net Income (Profit) i$8.52M$74.73M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PNTGSEM
Cash & Equivalents i$5.22M$59.69M
Total Current Assets i$123.89M$1.02B
Total Current Liabilities i$87.97M$977.65M
Long-Term Debt i$312.74M$2.48B
Total Shareholders Equity i$323.03M$2.00B
Retained Earnings i$65.00M$770.15M
Property, Plant & Equipment i$311.61M$908.10M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PNTGSEM
Operating Cash Flow i$850,000$129.35M
Capital Expenditures i$-1.96M$-63.43M
Free Cash Flow i$-23.19M$62.00M
Debt Repayment i$-44.00M$-1.82B
Common Stock Repurchase iN/A$-19.98M

Short Interest & Institutional Ownership Analysis

MetricPNTGSEM
Shares Short i736,3893.83M
Short Ratio i2.563.80
Short % of Float i0.03%0.07%
Average Daily Volume (10 Day) i247,9391,083,480
Average Daily Volume (90 Day) i306,8861,361,833
Shares Outstanding i34.37M128.96M
Float Shares i29.85M109.67M
% Held by Insiders i0.05%0.14%
% Held by Institutions i0.93%0.85%

Dividend Analysis & Yield Comparison: Pennant Group vs Select Medical

MetricPNTGSEM
Last 12-Month Dividend iN/A$9.82
Last 12-Month Dividend Yield iN/A65.77%
3-Year Avg Annual Dividend iN/A$3.44
3-Year Avg Dividend Yield iN/A4.54%
3-Year Total Dividends iN/A$10.31
Ex-Dividend DateN/AMar 03, 2025